Clinical Trials Browser

Phase NA × Melanoma × Immunohistochemistry × Clear all

NCT02236546 2017-04-13

FDG-PET in Advanced Melanoma

Phase NA Terminated

3 enrolled 4 charts

Melanoma

NCT00049010 2016-07-01

Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma

Phase NA Completed

Melanoma